Bausch Health expects to raise full-year 2026 adjusted EBITDA excluding Acquired IPR&D guidance

Bitget2026/10/12 10:49

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Bausch Health flagged an increase to full-year 2026 adjusted EBITDA excluding acquired IPR&D guidance, based on preliminary third-quarter results.
The update cited stronger business performance expectations for the rest of 2026, supported by prevailing foreign exchange rates.
The company reported 13 consecutive quarters of year-over-year revenue growth and adjusted EBITDA growth, excluding Bausch + Lomb.
More detail is expected with third-quarter results on Oct. 28.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bausch Health Companies Inc. published the original content used to generate this news brief on October 12, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

A survey released by the New York Fed on Friday shows that in October, sales prices for service sector firms increased at the fastest pace since 2022, with input costs remaining robust and supply conditions continuing to deteriorate. Businesses’ pessimism about the commercial outlook has significantly intensified, with the overall business activity index falling by 12 points from the previous month to minus 20.7, marking the weakest reading since March.

华尔街见闻•2026/10/16 22:46